• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Japanese attitudes towards truth disclosure in cancer.

作者信息

Tanida N

机构信息

Department of Internal Medicine 4, Hyogo College of Medicine, Japan.

出版信息

Scand J Soc Med. 1994 Mar;22(1):50-7. doi: 10.1177/140349489402200109.

DOI:10.1177/140349489402200109
PMID:8029667
Abstract

Despite the increasing concerns of truth disclosure, most cancer patients are not told the truth about their disease in Japan. The author has tried to provide some insight into this issue by evaluating results from questionnaires given to hospital patients, clients in a mass cancer survey, and doctors of a college hospital. Results showed that 72% of patients and 83% of clients wanted to be told the truth, but only 33% and 34% of them thought that the truth should be told to cancer patients. These attitudes of patients and clients regarding truth disclosure were more positive than those of the general public and health care workers in previous studies. At present, 13% of doctors inform cancer patients of their disease. These trends indicate that the Japanese attitude toward avoiding truth disclosure stems primarily from paternalism but is also influenced by social characteristics including insufficient understanding of this issue. Open discussion involving all factions of society is necessary to attain a better understanding of this issue and to promote eventual truth disclosure.

摘要

相似文献

1
Japanese attitudes towards truth disclosure in cancer.
Scand J Soc Med. 1994 Mar;22(1):50-7. doi: 10.1177/140349489402200109.
2
Informed consent and truth telling to cancer patients.向癌症患者告知并征得知情同意。
Gastroenterol Jpn. 1991 Dec;26(6):789-92. doi: 10.1007/BF02782871.
3
Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States.伦理决策与患者自主权:日本和美国医生与患者的比较
Chest. 2000 Oct;118(4):1172-82. doi: 10.1378/chest.118.4.1172.
4
Autonomy, beneficence, and informed consent: rethinking the connections. I.自主性、善行和知情同意:重新思考它们之间的联系。一
Cancer Invest. 1986;4(3):257-69. doi: 10.3109/07357908609018455.
5
Autonomy, beneficence, and informed consent: rethinking the connections. II.自主性、善行与知情同意:重新思考它们之间的联系。第二部分
Cancer Invest. 1986;4(4):353-61. doi: 10.3109/07357908609017514.
6
Attitudes of a Mediterranean population to the truth-telling issue.地中海地区人群对讲真话问题的态度。
J Med Ethics. 1992 Jun;18(2):67-74. doi: 10.1136/jme.18.2.67.
7
Family surrogacy and cancer disclosure: physician-family negotiation of an ethical dilemma in Japan.家庭代孕与癌症告知:日本医生与家属就伦理困境的协商
J Palliat Care. 1999 Autumn;15(3):31-42.
8
[The physician when facing diagnosis and prognosis of advanced cancer].[面对晚期癌症的诊断与预后时的医生]
Rev Assoc Med Bras (1992). 2007 Jan-Feb;53(1):68-74. doi: 10.1590/s0104-42302007000100023.
9
Public passages, personal passages, and reluctant passages: notes on investigating cancer disclosure practices in Japan.公共通道、个人通道与不情愿的通道:关于日本癌症披露行为调查的笔记
J Med Humanit. 2000 Spring;21(1):3-13. doi: 10.1023/a:1009027930787.
10
Consent.同意。
Br Med J (Clin Res Ed). 1985 Dec 14;291(6510):1700-1. doi: 10.1136/bmj.291.6510.1700.

引用本文的文献

1
Disclosure of true medical information: the case of Bangladesh.披露真实医疗信息:孟加拉国案例。
BMC Med Ethics. 2024 Oct 17;25(1):112. doi: 10.1186/s12910-024-01115-y.
2
Biopsychosocial correlates of hope in Asian patients with cancer: a systematic review.癌症亚洲患者希望的心理社会生物学相关因素:系统综述。
BMJ Open. 2016 Oct 6;6(10):e012087. doi: 10.1136/bmjopen-2016-012087.
3
Disclosing the truth: a dilemma between instilling hope and respecting patient autonomy in everyday clinical practice.披露真相:日常临床实践中在给予希望与尊重患者自主权之间的两难困境。
Glob J Health Sci. 2013 Dec 20;6(2):128-37. doi: 10.5539/gjhs.v6n2p128.
4
Causal attributions to epidemiological risk factors and their associations to later psychological adjustment among Japanese breast cancer patients.日本乳腺癌患者对流行病学风险因素的因果归因及其与后期心理调适的关联。
Support Care Cancer. 2009 Jan;17(1):3-9. doi: 10.1007/s00520-008-0446-9. Epub 2008 Apr 2.
5
Psychological process from hospitalization to death among uninformed terminal liver cancer patients in Japan.日本未被告知病情的晚期肝癌患者从住院到死亡的心理过程。
BMC Palliat Care. 2006 Sep 4;5:6. doi: 10.1186/1472-684X-5-6.
6
Cultural context in medical ethics: lessons from Japan.医学伦理学中的文化背景:来自日本的经验教训。
Philos Ethics Humanit Med. 2006 Apr 3;1(1):E4. doi: 10.1186/1747-5341-1-4.
7
Evaluation of end of life care in cancer patients at a teaching hospital in Japan.日本一家教学医院对癌症患者临终关怀的评估。
J Med Ethics. 2004 Jun;30(3):264-7. doi: 10.1136/jme.2003.000125.
8
Patients' preferences for involvement in treatment decision making in Japan.日本患者对参与治疗决策的偏好。
BMC Fam Pract. 2004 Mar 1;5:1. doi: 10.1186/1471-2296-5-1.
9
Cultural barriers in oncology: issues in obtaining medical informed consent from Japanese-American elders in Hawaii.肿瘤学中的文化障碍:从夏威夷日裔美国老年人处获取医疗知情同意书的问题
J Cross Cult Gerontol. 1998;13(3):265-79. doi: 10.1023/a:1006532713142.
10
[Attitudes of health centre users to diagnoses of terminal illness].[健康中心使用者对绝症诊断的态度]
Aten Primaria. 2002 Oct 31;30(7):449-54. doi: 10.1016/s0212-6567(02)79070-7.